JPRN-UMIN000000966已完成2 期
Evaluation of the usefulness of letrozole as hormone therapy for postmenopausal patients with Ductal Carcinoma In Situ (DCIS) - Evaluation of the usefulness of letrozole as hormone therapy for postmenopausal patients with Ductal Carcinoma In Situ (DCIS)
St. Luke's International Hospital0 个研究点目标入组 20 人开始时间: 2008年1月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •(1)Patients receiving drugs having a potential influence on the status of sex hormones (hormone replacement therapy, raloxifene, etc.). (However, patients after washout for at least 2 months can be enrolled.) (2)Patients with bilateral DCIS. (3)Patients within 30 days after completion of treatment with the investigational drugs.
研究者
相似试验
已完成
2 期
Evaluation of the usefulness of letrozole as neoadjuvant hormone therapy for postmenopausal patients with hormone receptor-positive breast cancerBreast cancerJPRN-UMIN000003699St. Luke's International Hospital60
尚未招募
Unknown
Investigating the effect of letrozole in the treatment of ectopic pregnancyEctopic pregnancyIRCT20220902055855N1Tehran University of Medical Sciences75
尚未招募
3 期
Comparison of letrozole and Cetrolix acetate in the prevention of ovarian hyperstimulation syndromeIRCT20240627062268N1Iran University of Medical Sciences110
已完成
3 期
Evaluation of the effect of letrozole in the prevention of ovarian hyperstimulation syndromeIRCT20180313039085N1Esfahan University of Medical Sciences40
招募中
不适用
The effect of letrozole on treatment of endometriosis-related infertilityIRCT20150310021420N4Tehran University of Medical Sciences144